Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Prospective Imaging Trial Assessing Gadoteridol Retention in the Deep Brain Nuclei of Women Undergoing Breast MRI.

Neal CH, Pujara AC, Srinivasan A, Chenevert TL, Malyarenko D, Khalatbari S, Helvie MA, Noroozian M, Jeruss JS, Pearlman MD, Davenport MS.

Acad Radiol. 2020 Feb 24. pii: S1076-6332(20)30034-9. doi: 10.1016/j.acra.2020.01.007. [Epub ahead of print]

PMID:
32107123
2.

Spiral T1 Spin-Echo for Routine Postcontrast Brain MRI Exams: A Multicenter Multireader Clinical Evaluation.

Ooi MB, Li Z, Robison RK, Wang D, Anderson AG 3rd, Zwart NR, Bakhru A, Nagaraj S, Mathews T, Hey S, Koonen JJ, Dimitrov IE, Friel HT, Lu Q, Obara M, Saha I, Wang H, Wang Y, Zhao Y, Temkit M, Hu HH, Chenevert TL, Togao O, Tkach JA, Nagaraj UD, Pinho MC, Gupta RK, Small JE, Kunst MM, Karis JP, Andre JB, Miller JH, Pinter NK, Pipe JG.

AJNR Am J Neuroradiol. 2020 Feb;41(2):238-245. doi: 10.3174/ajnr.A6409. Epub 2020 Feb 6.

PMID:
32029467
3.

Metal Artifact Reduction in Cardiovascular MRI for Accurate Myocardial Scar Assessment in Patients With Cardiac Implantable Electronic Devices.

Runge M, Ibrahim EH, Bogun F, Attili A, Mahani MG, Pang Y, Horwood L, Chenevert TL, Stojanovska J.

AJR Am J Roentgenol. 2019 Sep;213(3):555-561. doi: 10.2214/AJR.19.21187. Epub 2019 May 23.

PMID:
31120781
4.

Diffusion-weighted MRI in Multicenter Trials of Breast Cancer.

Partridge SC, Newitt DC, Chenevert TL, Rosen MA, Hylton NM; ACRIN 6698 Trial Team and I-SPY 2 Trial Investigators.

Radiology. 2019 May;291(2):546. doi: 10.1148/radiol.2019190446. Epub 2019 Apr 2. No abstract available.

PMID:
30938630
5.

Histotripsy Clot Liquefaction in a Porcine Intracerebral Hemorrhage Model.

Gerhardson T, Sukovich JR, Chaudhary N, Chenevert TL, Ives K, Hall TL, Camelo-Piragua S, Xu Z, Pandey AS.

Neurosurgery. 2020 Mar 1;86(3):429-436. doi: 10.1093/neuros/nyz089.

PMID:
30924501
6.

Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO).

Bell LC, Semmineh N, An H, Eldeniz C, Wahl R, Schmainda KM, Prah MA, Erickson BJ, Korfiatis P, Wu C, Sorace AG, Yankeelov TE, Rutledge N, Chenevert TL, Malyarenko D, Liu Y, Brenner A, Hu LS, Zhou Y, Boxerman JL, Yen YF, Kalpathy-Cramer J, Beers AL, Muzi M, Madhuranthakam AJ, Pinho M, Johnson B, Quarles CC.

Tomography. 2019 Mar;5(1):110-117. doi: 10.18383/j.tom.2018.00041.

7.

The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II.

Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Malyarenko DI, Aryal MP, LaViolette PS, Oborski MJ, O'Sullivan F, Abramson RG, Jafari-Khouzani K, Afzal A, Tudorica A, Moloney B, Gupta SN, Besa C, Kalpathy-Cramer J, Mountz JM, Laymon CM, Muzi M, Kinahan PE, Schmainda K, Cao Y, Chenevert TL, Taouli B, Yankeelov TE, Fennessy F, Li X.

Tomography. 2019 Mar;5(1):99-109. doi: 10.18383/j.tom.2018.00027.

8.

Multicenter Repeatability Study of a Novel Quantitative Diffusion Kurtosis Imaging Phantom.

Malyarenko DI, Swanson SD, Konar AS, LoCastro E, Paudyal R, Liu MZ, Jambawalikar SR, Schwartz LH, Shukla-Dave A, Chenevert TL.

Tomography. 2019 Mar;5(1):36-43. doi: 10.18383/j.tom.2018.00030.

9.

Repeatability of Quantitative Diffusion-Weighted Imaging Metrics in Phantoms, Head-and-Neck and Thyroid Cancers: Preliminary Findings.

Paudyal R, Konar AS, Obuchowski NA, Hatzoglou V, Chenevert TL, Malyarenko DI, Swanson SD, LoCastro E, Jambawalikar S, Liu MZ, Schwartz LH, Tuttle RM, Lee N, Shukla-Dave A.

Tomography. 2019 Mar;5(1):15-25. doi: 10.18383/j.tom.2018.00044.

10.

Comparison of Voxel-Wise and Histogram Analyses of Glioma ADC Maps for Prediction of Early Therapeutic Change.

Chenevert TL, Malyarenko DI, Galbán CJ, Gomez-Hassan DM, Sundgren PC, Tsien CI, Ross BD.

Tomography. 2019 Mar;5(1):7-14. doi: 10.18383/j.tom.2018.00049.

11.

A unique anisotropic R2 of collagen degeneration (ARCADE) mapping as an efficient alternative to composite relaxation metric (R2 -R1 ρ ) in human knee cartilage study.

Pang Y, Palmieri-Smith RM, Malyarenko DI, Swanson SD, Chenevert TL.

Magn Reson Med. 2019 Jun;81(6):3763-3774. doi: 10.1002/mrm.27621. Epub 2019 Feb 22.

PMID:
30793790
12.

Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).

Rahbar H, Zhang Z, Chenevert TL, Romanoff J, Kitsch AE, Hanna LG, Harvey SM, Moy L, DeMartini WB, Dogan B, Yang WT, Wang LC, Joe BN, Oh KY, Neal CH, McDonald ES, Schnall MD, Lehman CD, Comstock CE, Partridge SC.

Clin Cancer Res. 2019 Mar 15;25(6):1756-1765. doi: 10.1158/1078-0432.CCR-18-2967. Epub 2019 Jan 15.

13.

Multivoxel 1H-MR Spectroscopy Biometrics for Preoprerative Differentiation Between Brain Tumors.

Durmo F, Rydelius A, Cuellar Baena S, Askaner K, Lätt J, Bengzon J, Englund E, Chenevert TL, Björkman-Burtscher IM, Sundgren PC.

Tomography. 2018 Dec;4(4):172-181. doi: 10.18383/j.tom.2018.00051.

14.

Brain tissue iron quantification by MRI in intracerebral hemorrhage: Current translational evidence and pitfalls.

Chaudhary N, Pandey AS, Griauzde J, Gemmete JJ, Chenevert TL, Keep RF, Xi G.

J Cereb Blood Flow Metab. 2019 Mar;39(3):562-564. doi: 10.1177/0271678X18818911. Epub 2018 Dec 12. Review.

15.

Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials.

Shukla-Dave A, Obuchowski NA, Chenevert TL, Jambawalikar S, Schwartz LH, Malyarenko D, Huang W, Noworolski SM, Young RJ, Shiroishi MS, Kim H, Coolens C, Laue H, Chung C, Rosen M, Boss M, Jackson EF.

J Magn Reson Imaging. 2019 Jun;49(7):e101-e121. doi: 10.1002/jmri.26518. Epub 2018 Nov 19. Review.

PMID:
30451345
16.

Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.

Newitt DC, Zhang Z, Gibbs JE, Partridge SC, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Aliu S, Li W, Cimino L, Joe BN, Umphrey H, Ojeda-Fournier H, Dogan B, Oh K, Abe H, Drukteinis J, Esserman LJ, Hylton NM; ACRIN Trial Team and I-SPY 2 TRIAL Investigators.

J Magn Reson Imaging. 2019 Jun;49(6):1617-1628. doi: 10.1002/jmri.26539. Epub 2018 Oct 22.

PMID:
30350329
17.

Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.

Partridge SC, Zhang Z, Newitt DC, Gibbs JE, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Romanoff J, Cimino L, Joe BN, Umphrey HR, Ojeda-Fournier H, Dogan B, Oh K, Abe H, Drukteinis JS, Esserman LJ, Hylton NM; ACRIN 6698 Trial Team and I-SPY 2 Trial Investigators.

Radiology. 2018 Dec;289(3):618-627. doi: 10.1148/radiol.2018180273. Epub 2018 Sep 4.

18.

Water-fat magnetic resonance imaging quantifies relative proportions of brown and white adipose tissues: ex-vivo experiments.

Stojanovska J, Lumeng CN, Griffin C, Hernando D, Hoffmann U, Haft JW, Kim KM, Burant CF, Singer K, Tsodikov A, Long BD, Romano MA, Tang PC, Yang B, Chenevert TL.

J Med Imaging (Bellingham). 2018 Apr;5(2):024007. doi: 10.1117/1.JMI.5.2.024007. Epub 2018 Jun 29.

19.

Multimodal imaging provides insight into targeted therapy response in metastatic prostate cancer to the bone.

Hoff BA, Brisset JC, Galbán S, Van Dort M, Smith DC, Reichert ZR, Jacobson JA, Luker GD, Chenevert TL, Ross BD.

Am J Nucl Med Mol Imaging. 2018 Jun 5;8(3):189-199. eCollection 2018.

20.

Primary myelofibrosis evolving to an aplastic appearing marrow.

Schaefer JK, Choi SM, Luker GD, Chenevert TL, Ross BD, Talpaz M.

Clin Case Rep. 2018 May 31;6(7):1393-1395. doi: 10.1002/ccr3.1618. eCollection 2018 Jul.

21.

Validation of a DIXON-based fat quantification technique for the measurement of visceral fat using a CT-based reference standard.

Heckman KM, Otemuyiwa B, Chenevert TL, Malyarenko D, Derstine BA, Wang SC, Davenport MS.

Abdom Radiol (NY). 2019 Jan;44(1):346-354. doi: 10.1007/s00261-018-1678-x.

PMID:
29946923
22.

Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project.

Schmainda KM, Prah MA, Rand SD, Liu Y, Logan B, Muzi M, Rane SD, Da X, Yen YF, Kalpathy-Cramer J, Chenevert TL, Hoff B, Ross B, Cao Y, Aryal MP, Erickson B, Korfiatis P, Dondlinger T, Bell L, Hu L, Kinahan PE, Quarles CC.

AJNR Am J Neuroradiol. 2018 Jun;39(6):1008-1016. doi: 10.3174/ajnr.A5675. Epub 2018 May 24.

23.

Toward uniform implementation of parametric map Digital Imaging and Communication in Medicine standard in multisite quantitative diffusion imaging studies.

Malyarenko D, Fedorov A, Bell L, Prah M, Hectors S, Arlinghaus L, Muzi M, Solaiyappan M, Jacobs M, Fung M, Shukla-Dave A, McManus K, Boss M, Taouli B, Yankeelov TE, Quarles CC, Schmainda K, Chenevert TL, Newitt DC.

J Med Imaging (Bellingham). 2018 Jan;5(1):011006. doi: 10.1117/1.JMI.5.1.011006. Epub 2017 Oct 30.

24.

Quantitative magnetic resonance imaging phantoms: A review and the need for a system phantom.

Keenan KE, Ainslie M, Barker AJ, Boss MA, Cecil KM, Charles C, Chenevert TL, Clarke L, Evelhoch JL, Finn P, Gembris D, Gunter JL, Hill DLG, Jack CR Jr, Jackson EF, Liu G, Russek SE, Sharma SD, Steckner M, Stupic KF, Trzasko JD, Yuan C, Zheng J.

Magn Reson Med. 2018 Jan;79(1):48-61. doi: 10.1002/mrm.26982. Epub 2017 Oct 30. Review.

25.

Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network.

Newitt DC, Malyarenko D, Chenevert TL, Quarles CC, Bell L, Fedorov A, Fennessy F, Jacobs MA, Solaiyappan M, Hectors S, Taouli B, Muzi M, Kinahan PE, Schmainda KM, Prah MA, Taber EN, Kroenke C, Huang W, Arlinghaus LR, Yankeelov TE, Cao Y, Aryal M, Yen YF, Kalpathy-Cramer J, Shukla-Dave A, Fung M, Liang J, Boss M, Hylton N.

J Med Imaging (Bellingham). 2018 Jan;5(1):011003. doi: 10.1117/1.JMI.5.1.011003. Epub 2017 Oct 10.

26.

Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study.

Bane O, Hectors SJ, Wagner M, Arlinghaus LL, Aryal MP, Cao Y, Chenevert TL, Fennessy F, Huang W, Hylton NM, Kalpathy-Cramer J, Keenan KE, Malyarenko DI, Mulkern RV, Newitt DC, Russek SE, Stupic KF, Tudorica A, Wilmes LJ, Yankeelov TE, Yen YF, Boss MA, Taouli B.

Magn Reson Med. 2018 May;79(5):2564-2575. doi: 10.1002/mrm.26903. Epub 2017 Sep 14.

27.

Computational Challenges and Collaborative Projects in the NCI Quantitative Imaging Network.

Farahani K, Kalpathy-Cramer J, Chenevert TL, Rubin DL, Sunderland JJ, Nordstrom RJ, Buatti J, Hylton N.

Tomography. 2016 Dec;2(4):242-249. doi: 10.18383/j.tom.2016.00265.

28.

Brain Connectivity Patterns Dissociate Action of Specific Acupressure Treatments in Fatigued Breast Cancer Survivors.

Harris RE, Ichesco E, Cummiford C, Hampson JP, Chenevert TL, Basu N, Zick SM.

Front Neurol. 2017 Jun 23;8:298. doi: 10.3389/fneur.2017.00298. eCollection 2017.

29.

Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.

Oral EA, Reilly SM, Gomez AV, Meral R, Butz L, Ajluni N, Chenevert TL, Korytnaya E, Neidert AH, Hench R, Rus D, Horowitz JF, Poirier B, Zhao P, Lehmann K, Jain M, Yu R, Liddle C, Ahmadian M, Downes M, Evans RM, Saltiel AR.

Cell Metab. 2017 Jul 5;26(1):157-170.e7. doi: 10.1016/j.cmet.2017.06.006.

30.

Intrathoracic Fat Measurements Using Multidetector Computed Tomography (MDCT): Feasibility and Reproducibility.

Stojanovska J, Ibrahim EH, Chughtai AR, Jackson EA, Gross BH, Jacobson JA, Tsodikov A, Daneshvar B, Long BD, Chenevert TL, Kazerooni EA.

Tomography. 2017 Mar;3(1):33-40. doi: 10.18383/j.tom.2017.00103.

31.

MRI-Guided Stereotactic Biopsy of Murine GBM for Spatiotemporal Molecular Genomic Assessment.

Galbán S, Al-Holou WN, Wang H, Welton AR, Heist K, Hu XK, Verhaak RG, Zhu Y, Espinoza C, Chenevert TL, Hoff BA, Galbán CJ, Ross BD.

Tomography. 2017 Mar;3(1):9-15. doi: 10.18383/j.tom.2017.00112.

32.

Semiautomated Workflow for Clinically Streamlined Glioma Parametric Response Mapping.

Keith L, Ross BD, Galbán CJ, Luker GD, Galbán S, Zhao B, Guo X, Chenevert TL, Hoff BA.

Tomography. 2016 Dec;2(4):267-275. doi: 10.18383/j.tom.2016.00181.

33.

Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort.

Ajluni N, Meral R, Neidert AH, Brady GF, Buras E, McKenna B, DiPaola F, Chenevert TL, Horowitz JF, Buggs-Saxton C, Rupani AR, Thomas PE, Tayeh MK, Innis JW, Omary MB, Conjeevaram H, Oral EA.

Clin Endocrinol (Oxf). 2017 May;86(5):698-707. doi: 10.1111/cen.13311. Epub 2017 Mar 27.

34.

QIN DAWG Validation of Gradient Nonlinearity Bias Correction Workflow for Quantitative Diffusion-Weighted Imaging in Multicenter Trials.

Malyarenko DI, Wilmes LJ, Arlinghaus LR, Jacobs MA, Huang W, Helmer KG, Taouli B, Yankeelov TE, Newitt D, Chenevert TL.

Tomography. 2016 Dec;2(4):396-405. doi: 10.18383/j.tom.2016.00214.

35.

Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis.

Davenport MS, Malyarenko DI, Pang Y, Hussain HK, Chenevert TL.

AJR Am J Roentgenol. 2017 Feb;208(2):328-336. doi: 10.2214/AJR.16.16860. Epub 2016 Dec 8.

PMID:
27929673
36.

Imaging biomarker roadmap for cancer studies.

O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC.

Nat Rev Clin Oncol. 2017 Mar;14(3):169-186. doi: 10.1038/nrclinonc.2016.162. Epub 2016 Oct 11. Review.

37.

Impact of uncertainty in longitudinal T1 measurements on quantification of dynamic contrast-enhanced MRI.

Aryal MP, Chenevert TL, Cao Y.

NMR Biomed. 2016 Apr;29(4):411-9. Epub 2016 Jan 21.

38.

A Pilot Study of Quantitative MRI Parametric Response Mapping of Bone Marrow Fat for Treatment Assessment in Myelofibrosis.

Luker GD, Nguyen HM, Hoff BA, Galbán CJ, Hernando D, Chenevert TL, Talpaz M, Ross BD.

Tomography. 2016 Mar;2(1):67-78.

39.

The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.

Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Malyarenko DI, Aryal MP, LaViolette PS, Oborski MJ, O'Sullivan F, Abramson RG, Jafari-Khouzani K, Afzal A, Tudorica A, Moloney B, Gupta SN, Besa C, Kalpathy-Cramer J, Mountz JM, Laymon CM, Muzi M, Schmainda K, Cao Y, Chenevert TL, Taouli B, Yankeelov TE, Fennessy F, Li X.

Tomography. 2016 Mar;2(1):56-66.

40.

Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model.

Lemasson B, Wang H, Galbán S, Li Y, Zhu Y, Heist KA, Tsein C, Chenevert TL, Rehemtulla A, Galbán CJ, Holland EC, Ross BD.

Neoplasia. 2016 Feb;18(2):82-9. doi: 10.1016/j.neo.2015.11.014.

41.

Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.

Masch WR, Wang PI, Chenevert TL, Junck L, Tsien C, Heth JA, Sundgren PC.

Acad Radiol. 2016 May;23(5):569-76. doi: 10.1016/j.acra.2015.11.015. Epub 2016 Feb 23.

42.

Correction of Gradient Nonlinearity Bias in Quantitative Diffusion Parameters of Renal Tissue with Intra Voxel Incoherent Motion.

Malyarenko DI, Pang Y, Senegas J, Ivancevic MK, Ross BD, Chenevert TL.

Tomography. 2015 Dec;1(2):145-151.

43.

Diffusion MRI in early cancer therapeutic response assessment.

Galbán CJ, Hoff BA, Chenevert TL, Ross BD.

NMR Biomed. 2017 Mar;30(3). doi: 10.1002/nbm.3458. Epub 2016 Jan 15. Review.

44.

Development of a Multiparametric Voxel-Based Magnetic Resonance Imaging Biomarker for Early Cancer Therapeutic Response Assessment.

Galbán CJ, Lemasson B, Hoff BA, Johnson TD, Sundgren PC, Tsien C, Chenevert TL, Ross BD.

Tomography. 2015 Sep;1(1):44-52.

45.

Body diffusion kurtosis imaging: Basic principles, applications, and considerations for clinical practice.

Rosenkrantz AB, Padhani AR, Chenevert TL, Koh DM, De Keyzer F, Taouli B, Le Bihan D.

J Magn Reson Imaging. 2015 Nov;42(5):1190-202. doi: 10.1002/jmri.24985. Epub 2015 Jun 26. Review.

46.

Apparent diffusion coefficient is highly reproducible on preclinical imaging systems: Evidence from a seven-center multivendor study.

Doblas S, Almeida GS, Blé FX, Garteiser P, Hoff BA, McIntyre DJ, Wachsmuth L, Chenevert TL, Faber C, Griffiths JR, Jacobs AH, Morris DM, O'Connor JP, Robinson SP, Van Beers BE, Waterton JC.

J Magn Reson Imaging. 2015 Dec;42(6):1759-64. doi: 10.1002/jmri.24955. Epub 2015 May 26.

47.

Demonstration of nonlinearity bias in the measurement of the apparent diffusion coefficient in multicenter trials.

Malyarenko DI, Newitt D, J Wilmes L, Tudorica A, Helmer KG, Arlinghaus LR, Jacobs MA, Jajamovich G, Taouli B, Yankeelov TE, Huang W, Chenevert TL.

Magn Reson Med. 2016 Mar;75(3):1312-23. doi: 10.1002/mrm.25754. Epub 2015 May 2.

48.

Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.

Brisset JC, Hoff BA, Chenevert TL, Jacobson JA, Boes JL, Galbán S, Rehemtulla A, Johnson TD, Pienta KJ, Galbán CJ, Meyer CR, Schakel T, Nicolay K, Alva AS, Hussain M, Ross BD.

PLoS One. 2015 Apr 10;10(4):e0123877. doi: 10.1371/journal.pone.0123877. eCollection 2015.

49.

Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy.

Galbán CJ, Ma B, Malyarenko D, Pickles MD, Heist K, Henry NL, Schott AF, Neal CH, Hylton NM, Rehemtulla A, Johnson TD, Meyer CR, Chenevert TL, Turnbull LW, Ross BD.

PLoS One. 2015 Mar 27;10(3):e0122151. doi: 10.1371/journal.pone.0122151. eCollection 2015.

50.

Gradient nonlinearity correction to improve apparent diffusion coefficient accuracy and standardization in the american college of radiology imaging network 6698 breast cancer trial.

Newitt DC, Tan ET, Wilmes LJ, Chenevert TL, Kornak J, Marinelli L, Hylton N.

J Magn Reson Imaging. 2015 Oct;42(4):908-19. doi: 10.1002/jmri.24883. Epub 2015 Mar 11.

Supplemental Content

Loading ...
Support Center